Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Groothuis

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 27, 2003
Safety of palivizumab in preterm infants 29 to 32 weeks' gestational age without chronic lung disease to prevent serious respiratory syncytial virus infectionJ R Groothuis
Pediatrics|November 5, 1999
The pitfalls of using managed care databases in cost-effectiveness researchJ R Groothuis
The New England Journal of Medicine|December 29, 1998
Respiratory syncytial virus immune globulin and conflict of interestJ R Groothuis
The Journal of Pediatrics|May 1, 1994
Role of antibody and use of respiratory syncytial virus (RSV) immune globulin to prevent severe RSV disease in high-risk childrenJ R Groothuis
Antiviral Research|January 1, 1994
The role of RSV neutralizing antibodies in the treatment and prevention of respiratory syncytial virus infection in high-risk childrenJ R Groothuis
The Pediatric Infectious Disease Journal|June 23, 2001
Safety and tolerance of palivizumab administration in a large Northern Hemisphere trial. Northern Hemisphere Expanded Access Study GroupJ R Groothuis
Clinics in Perinatology|June 1, 1985
Twins and twin families. A practical guide to outpatient managementJ R Groothuis
The Pediatric Infectious Disease Journal|May 1, 1994
Role of antibody and the use of respiratory syncytial virus immunoglobulin in the prevention of respiratory syncytial virus disease in preterm infants with and without bronchopulmonary dysplasiaJ R Groothuis
International Journal of Antimicrobial Agents|February 1, 1993
Immunoprophylaxis and immunotherapy: role in the prevention and treatment of repiratory syncytial virusJ R Groothuis, E A Simoes
Primary Care|September 1, 1984
Childhood asthma. Considerations in establishing treatment programsJ V Lustig, J R Groothuis
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 27, 2003
Safety of palivizumab in preterm infants 29 to 32 weeks' gestational age without chronic lung disease to prevent serious respiratory syncytial virus infectionJ R Groothuis
Pediatrics|November 5, 1999
The pitfalls of using managed care databases in cost-effectiveness researchJ R Groothuis
The New England Journal of Medicine|December 29, 1998
Respiratory syncytial virus immune globulin and conflict of interestJ R Groothuis
The Journal of Pediatrics|May 1, 1994
Role of antibody and use of respiratory syncytial virus (RSV) immune globulin to prevent severe RSV disease in high-risk childrenJ R Groothuis
Antiviral Research|January 1, 1994
The role of RSV neutralizing antibodies in the treatment and prevention of respiratory syncytial virus infection in high-risk childrenJ R Groothuis
The Pediatric Infectious Disease Journal|June 23, 2001
Safety and tolerance of palivizumab administration in a large Northern Hemisphere trial. Northern Hemisphere Expanded Access Study GroupJ R Groothuis
Clinics in Perinatology|June 1, 1985
Twins and twin families. A practical guide to outpatient managementJ R Groothuis
The Pediatric Infectious Disease Journal|May 1, 1994
Role of antibody and the use of respiratory syncytial virus immunoglobulin in the prevention of respiratory syncytial virus disease in preterm infants with and without bronchopulmonary dysplasiaJ R Groothuis
International Journal of Antimicrobial Agents|February 1, 1993
Immunoprophylaxis and immunotherapy: role in the prevention and treatment of repiratory syncytial virusJ R Groothuis, E A Simoes
Primary Care|September 1, 1984
Childhood asthma. Considerations in establishing treatment programsJ V Lustig, J R Groothuis
Pageof 5